Results 91 to 100 of about 1,789 (171)

Update on microbicide research and development-seeking new HIV prevention tools for women [PDF]

, 2011
Women and girls are especially vulnerable to HIV infection in sub-Saharan Africa, and in some of those countries, prevalence among young women can be up to 3 times higher than among men of the same age.
Kaptur, PE, Mertenskoetter, T
core   +3 more sources

2016 Pipeline Report HIV and TB [PDF]

, 2016
HIV and TB: Drugs, Diagnostics, Vaccines, Preventive Technologies, Research Toward a Cure, and Immune-Based and Gene Therapies in ...
Erica Lessem, Lindsay McKenna, Mark Harrington, Mike Frick, Polly Clayden, Richard Jefferys, Simon Collins, Tim Horn   +7 more
core  

Views among Malawian women about joining HIV prevention clinical trials when pregnant

AIDS Research and Therapy, 2020
Background The pressing need to expand the biomedical HIV prevention evidence base during pregnancy is now increasingly recognized. Women’s views regarding participation in such trials and initiating PrEP while pregnant are critical to inform evolving ...
Kristen Sullivan, Tiwonge Mtande, Elana Jaffe, Nora Rosenberg, Chifundo Zimba, Irving Hoffman, Maggie Little, Ruth Faden, Anne Drapkin Lyerly   +8 more
doaj   +1 more source

Griffithsin Retains Anti-HIV-1 Potency with Changes in gp120 Glycosylation and Complements Broadly Neutralizing Antibodies PGT121 and PGT126. [PDF]

, 2019
Griffithsin (Grft) is an antiviral lectin that has been shown to potently inhibit HIV-1 by binding high-mannose N-linked glycosylation sites on HIV-1 gp120.
Fischer, Kathryn, LiWang, Patricia J, Nguyen, Kimberly   +2 more
core  

Anti-Retroviral–Based HIV Pre-Exposure Prophylaxis for Women: Recent Advances and Next Steps [PDF]

, 2017
There is a daunting challenge to prevent human immunodeficiency virus (HIV) acquisition in women at high risk of acquiring HIV. Of the 37 million people globally living with HIV, more than half are women.
Kiweewa, Flavia Matovu, Kiweewa, Francis, Mugwanya, Kenneth K.   +2 more
core   +1 more source

“People have options”: a qualitative study of experiences and influences of PrEP choice among women in South Africa

Journal of the International AIDS Society
Introduction Long‐acting injectable cabotegravir and dapivirine vaginal ring were recently introduced in South Africa through demonstration projects, providing additional HIV prevention options to oral pre‐exposure prophylaxis (PrEP). PrEP choice marks a
Siphokazi Dada, Faith Mary Musvipwa, Fatima Abegail Cholo, Melanie Pleaner, Alison Kutywayo, Vusile Butler, Catherine Elizabeth Martin, Saiqa Mullick   +7 more
doaj   +1 more source

Comparative efficacy of topical microbicides in the prevention of HIV transmission – results from a systematic review and network meta-analysis [PDF]

Introduction and aim. Preventing new HIV infections is crucial, particularly for women and girls at high risk. Vaginal microbi cides offer a female-controlled HIV prevention method.
Kumar, Suresh, Lee, E Lyn, Noreen, Nabeela, Shanmugham, Suresh, Smales, Frederick Charles, Veettil, Sajesh K.   +5 more
core   +2 more sources

User and healthcare provider early experiences with the PrEP ring: a quantitative study on the introduction of a new PrEP method in Eswatini

Journal of the International AIDS Society
Introduction Eswatini prepared for the national rollout of HIV pre‐exposure prophylaxis (PrEP) choice through a mixed‐method demonstration study introducing the PrEP dapivirine vaginal ring in 12 Ministry of Health‐supported sites. The Eswatini PrEP Ring
Anita Hettema, Siphesihle Shongwe, Haley Sisel, Mxolisi Khumalo, Ncediso Gama, Nolwazi Khanyile, Buyile Mahlalela, Sindy Nana Matse, Jill M. Peterson   +8 more
doaj   +1 more source

Qualitative focus group discussions exploring PrEP method and service delivery preferences among female sex workers and their managers in four Zambian provinces

BMJ Public Health
Objectives To describe the experiences of oral HIV pre-exposure prophylaxis (PrEP) use, preferences comparing oral PrEP to future long-acting PrEP products (the dapivirine vaginal ring (PrEP ring) and injectable cabotegravir (CAB PrEP)), and service ...
Holly M Burke, Emily Evens, Tendai Munthali, Featherstone Mangunje, Mercy L Kotaka, Bupe Musonda, Musonda Musonda, Catherine S Todd   +7 more
doaj   +1 more source

Characterization of porous, dexamethasone-releasing polyurethane coatings for glucose sensors. [PDF]

, 2014
Commercially available implantable needle-type glucose sensors for diabetes management are robust analytically but can be unreliable clinically primarily due to tissue-sensor interactions.
Klitzman, Bruce, Reichert, William M, Vallejo-Heligon, Suzana G   +2 more
core   +1 more source